Residual mediastinal mass after treatment of Hodgkin's disease: A decision analysis
- 30 June 1992
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 38 (2), 166-175
- https://doi.org/10.1016/0306-9877(92)90089-u
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Planning mantle radiation therapy in patients with Hodgkin disease: role of gallium-67 scintigraphyAmerican Journal of Roentgenology, 1988
- The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease.Journal of Clinical Oncology, 1988
- Residual mass in lymphoma may not be residual disease.Journal of Clinical Oncology, 1988
- The significance of the residual mediastinal mass in treated Hodgkin's disease.Journal of Clinical Oncology, 1985
- The prognostic significance of mediastinal bulk in patients with stage IA-IVB Hodgkin's disease: A report from the Manchester Lymphoma GroupClinical Radiology, 1985
- High-dose gallium imaging in lymphomaThe American Journal of Medicine, 1983
- Post-Therapy CT-Detected Mass in Lymphoma PatientsJournal of Computer Assisted Tomography, 1982
- CT scan modification in the treatment of mediastinal Hodgkin's diseaseCancer, 1982
- Salvage Chemotherapy with ABVD in MOPP-Resistant Hodgkin's DiseaseAnnals of Internal Medicine, 1982
- Combination Chemotherapy in the Treatment of Advanced Hodgkin's DiseaseAnnals of Internal Medicine, 1970